EP3096781

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.)
Application Number
EP15701194A
Filing Date
Jan 22, 2015
Status
Granted And Under Opposition
Sep 30, 2022
Grant Date
Nov 2, 2022
External Links
Slate, Register

Biblio Summary

The patent EP3096781B1 was granted on Nov 2, 2022 by Centre National De La Recherche Scientifique (C.N.R.S.) The patent is currently Granted And Under Opposition.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMAN LIMITEDAug 1, 2023ADMISSIBLE

The table below shows the patents of Centre National De La Recherche Scientifique (C.N.R.S.) that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3152234Antibody Which Is Directed Against Galectin-9 And Is An Inhibitor Of The Suppressor Activity Of Regulatory T LymphocytesJun 26, 20241
EP3066203New Alzheimer'S Disease Animal ModelNov 8, 20231
EP2988757Treatment Of Skin Injuries Associated With Auto-Immune And Inflammatory Diseases Using The Arsenic Compound As2O5Jan 12, 20221